Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × LY2787106 × Classical hematology × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Interventions

fludarabine phosphate 12 Cyclosporine 8 Whole-Body Irradiation 7 Peripheral Blood Stem Cell Transplantation 7 Mycophenolic Acid 7 Cyclophosphamide 6 Cytarabine 5 Tacrolimus 4 Filgrastim 4 Carboplatin 4 Azacitidine 4 olaparib 3 Lenalidomide 3 Etoposide 3 Biopsy 3 venetoclax 2 tipifarnib 2 sargramostim 2 peginesatide 2 laromustine 2 hematide 2 enasidenib 2 alvocidib 2 aldesleukin 2 Vorinostat 2 Tretinoin 2 Thiotepa 2 Specimen Handling 2 Sirolimus 2 Rituximab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01340976 2018-10-03

A Phase 1 Study of LY2787106 in Cancer and Anemia

Eli Lilly and Company

Phase 1 Completed

33 enrolled 18 charts

Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡